Drug Profile
Sildenafil topical - Dare Bioscience/Strategic Science and Technologies
Alternative Names: Sildenafil citrate cream 5%; Sildenafil citrate topical cream (5%); Sildenafil cream (3.6%); Sildenafil cream 3.6%; SST-6007; Topical 5% sildenafil citrate creamLatest Information Update: 08 Apr 2024
Price :
$50
*
At a glance
- Originator Strategic Science & Technologies
- Developer Dare Bioscience; Strategic Science & Technologies
- Class Antihypertensives; Erectile dysfunction therapies; Phenyl ethers; Piperazines; Purines; Pyrazoles; Pyrimidinones; Small molecules; Sulfonamides
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Female sexual dysfunction
Most Recent Events
- 05 Apr 2024 Dare Bioscience has patent protection for Sildenafil in USA, Europe and in multiple countries worldwide
- 05 Apr 2024 Dare Bioscience has patents pending for Sildenafil in USA, Europe and in multiple countries worldwide
- 28 Mar 2024 The US FDA announces intention to provide feedback on the phase III trial in the second quarter of 2024